|
Sánchez-Más J, Lax A, Asensio-López Mdel C, Fernandez-Del Palacio MJ, Caballero L, Santarelli G, Januzzi JL, Pascual-Figal DA. Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers. Eur J Clin Invest. 2014 Jul;44(7):643-51. doi: 10.1111/eci.12282. PubMed PMID: 24837094.
AÑO: 2014; IF: 2.734
|
24837094
|
Asensio-Lopez MC, Sanchez-Mas J, Pascual-Figal DA, de Torre C, Valdes M, Lax A. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes. Free Radic Biol Med. 2014 Feb;67:19-29. doi: 10.1016/j.freeradbiomed.2013.11.003. PubMed PMID: 24231192.
AÑO: 2014; IF: 5.736
|
|
Sanchez-Mas J, Lax A, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor F, Januzzi JL, Pascual-Figal DA. Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol. 2014;172(1):e98-e101. doi: 10.1016/j.ijcard.2013.12.129. PubMed PMID: 24433619.
AÑO: 2014; IF: 4.036
|
|
Asensio-López MC, Sánchez-Más J, Pascual-Figal DA, Abenza S, Pérez-Martínez MT, Valdés M, Lax A. Involvement of ferritin heavy chain in the preventive effect of metformin against doxorubicin-induced cardiotoxicity. Free Radic Biol Med. 2013 Apr;57:188-200. doi: 10.1016/j.freeradbiomed.2012.09.009. PubMed PMID: 23000260.
AÑO: 2013; IF: 5.71
|
|
Pascual-Figal DA, Caballero L, Sanchez-Mas J, Lax A. Prognostic markers for acute heart failure. Expert Opin Med Diagn. 2013 Jul;7(4):379-92. doi: 10.1517/17530059.2013.814638. Review. PubMed PMID: 23795649.
AÑO: 2013
|